NEW YORK (GenomeWeb News) – Compugen today issued a statement in reaction to investors’ questions regarding the firm’s cash position and ability to fund its operations going forward, saying that it has sufficient cash on hand and marketable securities to run its business “well into 2010.”
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.

The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.

In Science this week: genetic overlap among many psychiatric disorders, and more.

The Economist writes that an increasing number of scientific journals don't do peer review.